# Midazolam Hydrochloride Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 26 - Latest FDA row update: 08/18/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Avet Pharmaceuticals, Inc. — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) — FDA availability: Limited Availability — updated: 08/18/2026 - Avet Pharmaceuticals, Inc. — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) — FDA availability: Available — updated: 08/18/2026 - Avet Pharmaceuticals, Inc. — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) — FDA availability: Available — updated: 08/18/2026 - Fresenius Kabi USA, LLC — Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) — FDA availability: Unavailable — updated: 08/04/2026 - Gland Pharma Limited — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) — FDA availability: Unavailable — updated: 07/22/2026 - Gland Pharma Limited — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) — FDA availability: Unavailable — updated: 07/22/2026 - Hikma Pharmaceuticals USA, Inc. — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) — FDA availability: Unavailable — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) — FDA availability: Available — updated: 08/13/2026 - Hospira, Inc., a Pfizer Company — Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) — FDA availability: Available — updated: 08/07/2026 - WG Critical Care — Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) — FDA availability: Available — updated: 08/17/2026 - WG Critical Care — Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) — FDA availability: Available — updated: 08/17/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/midazolam-hydrochloride-injection) - [JSON record](https://citefacts.com/shortages/midazolam-hydrochloride-injection.json)